CClinicalTrials.gg
RecruitingNCT05773014MOCAUpdated Jan 5, 2026

Digital vs. Speculum Exams for PPROM

An interventional study of Speculum Exams and Digital Exams in PPROM, sponsored by Washington University School of Medicine. Recruiting at 1 site in United States. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-05.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Sex
Female
01

Study summary

After preterm prelabor rupture of membranes (PPROM)[breaking of the amniotic sac prior to 37 weeks gestation in pregnancy], patients are recommended for inpatient admission and close monitoring for complications including preterm labor, intraamniotic infection (infection of the sac around the baby), and placental abruption (separation of the placenta from wall of the uterus). When evaluation of cervical dilation is clinically indicated, obstetricians traditionally perform sterile speculum exams due to concern for decrease in pregnancy latency (length of time between breaking the water and delivery) with sterile digital exams in retrospective studies. These studies are concerning, however, by the indications for the exams and are at risk for confounding by indication. This is a randomized, non-inferiority trial to examine if sterile digital versus speculum exams effect latency of pregnancy in patients with PPROM.

02

Conditions studied

  • PPROM

Browse trials for

Keywords

  • PPROM
  • speculum exam
  • preterm birth
  • preterm prelabor rupture of membranes
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • 22 weeks 0 days gestation to 33 weeks 5 days gestation
  • Clinical or laboratory confirmation of PPROM
  • At least 8 hours after rupture event
  • English speaking

Notably, for patients \<25 weeks, approach for enrollment will be deferred until after the patient has discussed their desires for fetal resuscitation with the care team and are at a gestational age where they would desire this resuscitation.

Exclusion criteria

Exclusion Criteria:

  • Contraindications to digital examination
  • COVID-19 positive on admission
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
86 participants (estimated)

Study arms

  • Active comparator
    Speculum Exams

    If a patient requires cervical evaluation after PPROM, their cervix will be evaluated with a sterile speculum exam. A sterile speculum with lubricating jelly will be inserted into the patient's vagina to visualize the cervix and visually estimate cervical dilation and effacement.

    Procedure: Speculum Exams

  • Active comparator
    Digital Exams

    If a patient requires cervical evaluation after PPROM, their cervix will be evaluated with a digital exam. The provider will wear sterile gloves with lubricating jelly and will palpate the cervix to assess cervical dilation, effacement, and station.

    Procedure: Digital Exams

Interventions

  • ProcedureSpeculum Exams

    Same as arm

  • ProcedureDigital Exams

    Same as arm

05

What researchers measure

Primary outcomes

  1. Pregnancy latency

    time from admission to delivery

    Time frame: up to 10 weeks

Secondary outcomes

  1. Maternal chorioamnionitis

    Per criteria of American College of Obstetricians and Gynecologists (ACOG): includes fever greater than or equal to 100.4 degrees Farenheit plus an additional sign such as fundal tenderness, white blood cell count \>15, purulent vaginal discharge, fetal tachycardia, or placental culture with finding of chorioamnionitis. Suspected chorioamnionitis can also be diagnosed with isolated fever \>102.2 degrees Fahrenheit

    Time frame: Prior to delivery

  2. Endomyometritis

    Clinical diagnosis of uterine infection after delivery, typically with fever and fundal tenderness

    Time frame: Within 2 weeks of delivery

  3. Maternal sepsis

    Defined as bacteremia with evidence of organ dysfunction

    Time frame: Within 2 weeks of delivery

  4. Maternal wound infections

    As diagnosed by the clinicians

    Time frame: Within 2 weeks of delivery

  5. Maternal intensive care unit (ICU) admission

    transfer to ICU or readmission to ICU

    Time frame: Within 2 weeks of delivery

  6. Maternal death

    Death of mother

    Time frame: Within 2 weeks postpartum

  7. Composite neonatal morbidity

    Need for respiratory support, neonatal sepsis, intraventricular hemorrhage, hypoxic ischemic encephalopathy, necrotizing enterocolitis, pneumonia, or neonatal demise

    Time frame: 28 days of life

  8. Length of neonatal intensive care unit (NICU) admission

    From delivery until discharge from the NICU

    Time frame: Up to 1 year

  9. Need for respiratory support

    One or more of the following: Continuous positive airway pressure (CPAP) or high-flow nasal cannula for at least 2 consecutive hours, supplemental oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 continuous hours, extracorporeal membrane oxygenation (ECMO), or mechanical ventilation

    Time frame: 28 days of life

  10. Neonatal sepsis at <72 hours of life

    must be confirmed on blood culture

    Time frame: Within 72 hours of birth

  11. Neonatal sepsis at >72 hours of life

    must be confirmed on blood culture

    Time frame: 28 days of life

  12. Neonatal intraventricular hemorrhage (IVH)

    Seen on head ultrasound

    Time frame: 28 days of life

  13. Necrotizing enterocolitis (NEC)

    As diagnosed by NICU team

    Time frame: 28 days of life

  14. Hypoxic ischemic encephalopathy

    As diagnosed by NICU team

    Time frame: 28 days of life

  15. Neonatal pneumonia

    As diagnosed by NICU team

    Time frame: 28 days of life

  16. Neonatal death

    As documented in the EMR

    Time frame: During NICU admission, up to 1 year

  17. Patient satisfaction with exams

    Survey regarding their experience with cervical exams

    Time frame: At delivery

06

Study locations

1 of 1 sites recruiting
  • Barnes Jewish Hospital
    St Louis, Missouri 63108, United States
    Recruiting
07

References and documents

Publications

  • Sukcharoen N, Vasuratna A. Effects of digital cervical examinations on duration of latency period, maternal and neonatal outcome in preterm premature rupture of membranes. J Med Assoc Thai. 1993 Apr;76(4):203-9. PubMed 8113640 ↗
  • Alexander JM, Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Meis PJ, Moawad AH, Iams JD, Vandorsten JP, Paul RH, Dombrowski MP, Roberts JM, McNellis D. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol. 2000 Oct;183(4):1003-7. doi: 10.1067/mob.2000.106765. PubMed 11035354 ↗
  • Lewis DF, Major CA, Towers CV, Asrat T, Harding JA, Garite TJ. Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol. 1992 Oct;80(4):630-4. PubMed 1407885 ↗
  • Singhal, S., Puri, M., & Gami, N. (2011). An analysis of factors affecting the duration of latency period and its impact on neonatal outcome in patients with PPROM. International Journal of Infertility and Fetal Medicine. 2012; 3(3): 87-91.

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT05773014
Lead sponsor
Washington University School of Medicine
Responsible party
Sponsor
First posted
Mar 17, 2023
Start date
Mar 27, 2023
Primary completion
Mar 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Jan 5, 2026

Study contacts

Nandini Raghuraman, MD
Contact
nraghuraman@wustl.edu
3142732939
Jaime Strickland
Contact
jaime.strickland@wustl.edu
3147471390

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion